The Law Office of Scott Righthand, P.C.
Free No-Obligation Case Evaluation
Call Today 415-544-0115

$56.9 Million Settlement Program Agreed to for Yaz Blood Clot Claims

Hundreds of plaintiffs have come forward with claims against the makers of Yaz, Yasmin, and Ocella for allegedly causing bloods cots and other medical complications over the last five years. The birth-control drugs have been tied to causing arterial blood clots, leading to both stroke and heart attacks. Bayer, makers of Yaz and Yasmin, and Barr Laboratories and Teva Pharmaceuticals, makers of Ocella, have all agreed to a settlement program that will reach nearly $56.9 million. This program will be used to settle claims that are pending in California, New Jersey, and Pennsylvania.

The settlement program is anticipated to cover all the blood clot claims brought against Bayer. The company does have the option to withdraw from the program if less than 97.5% of eligible claimants decide to bring forward legal action through this option.

Bayer Agrees to Program Without Admission

Last Monday, August 3rd, a judge in the Philadelphia Court of Common Pleas implemented strategic orders that are designed to help direct the settlement program. Multiple judges assisted in getting all parties to agree to the $56.9 million program for injured plaintiffs.

Despite agreeing to the program, Bayer holds strong with their opinion that their contraceptives don't carry any heightened risk for blood clots. Further, a Bayer spokesman argued that their labeling adequately disclosed any risks. Bayer agreed to the program but did not admit any wrongdoing or liability on their part. Their goal with this move was to avoid any additional costly litigation or distractions so that they could continue to focus on patients.

History of Claims Against Bayer's Oral Contraceptives

Previous lawsuits against Bayer were consolidated in 2009 and involved claims of venous blood clots, gallbladder injuries, deep vein thrombosis, and similar injuries. These claims were also connected to Bayer's oral contraceptives containing drospirenone.

As of today, Bayer has had to shovel out around $2 billion in payments to resolve venous clot claims in addition to amounts for settling gallbladder injuries claims. At the peak of the litigation, more than 12,000 claims were brought forward. However, this amount was later cut down to around 3,400.

This litigation has been very complicated and dragged out, which may be why all parties were finally on board with the recently agreed upon $56.9 million settlement program. The program aims to ensure that all who have suffered from blood clots due to Yaz, Yasmin, and Ocella are given the fair compensation they deserve for medical expenses, legal fees, and related costs.

No Comments

Leave a comment
Comment Information
Email Us For A Response

Get Started With A Free Case Evaluation

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

The Law Office of Scott Righthand, P.C.

275 Battery Street
Suite 1300A
San Francisco, CA 94111

Phone: 415-544-0115
Fax: 415-544-0116
San Francisco Law Office Map